Search results for "Gastro-intestinal"

showing 4 items of 4 documents

Extending in vitro digestion models to specific human populations: Perspectives, practical tools and bio-relevant information

2017

29th International Conference of the European-Federation-of-Food-Science-and-Technology (EFFoST) -- NOV 10-12, 2015 -- Athens, GREECE

Digestão in vitro0301 basic medicineEngineeringenzymic activityTECNOLOGIA DE ALIMENTOSFood digestionPopulationAvaliação de Riscopersonne âgéemodèle in vitro03 medical and health sciencesElderlyDigestion (alchemy)digestion in vitroSaúde HumanaGastricFood and Nutritionactivité gastrointestinaleIn vitro DigestionGastro-intestinal disorderseducationsenior citizensToxicoligiafibrose cystique2. Zero hungereducation.field_of_study030109 nutrition & dieteticsGastric emptyingScope (project management)business.industryactivité enzymatiqueIn vitro digestionFood digestion;In vitro digestion;Gastric;Infants;Elderly;Gastro-intestinal disordersFood DigestionIn vitro digestionGastric phBiotechnologySegurança AlimentarRisk analysis (engineering)Alimentation et Nutritionnutrition infantilebusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionInfantsRelevant informationFood ScienceBiotechnologyTrends in Food Science & Technology
researchProduct

Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study

2020

Data are relatively scarce on gastro-intestinal tuberculosis (GITB). Most studies are old and from single centers, or did not include immunosuppressed patients. Thus, we aimed to determine the clinical, radiological, and laboratory profiles of GITB. We included adults with proven GITB treated between 2000 and 2018. Patients were enrolled from 21 referral centers in 8 countries (Belgium, Egypt, France, Italy, Kazakhstan, Saudi Arabia, UK, and Turkey). One hundred four patients were included. Terminal ileum (n = 46, 44.2%), small intestines except terminal ileum (n = 36, 34.6%), colon (n = 29, 27.8%), stomach (n = 6, 5.7%), and perianal (one patient) were the sites of GITB. One-third of all p…

MaleCirrhosismedicine.medical_treatmentretrospective studylaparoscopyColonoscopymultimodal imagingComorbidityGastroenterologyprotionamide0302 clinical medicineLaparotomyAscitesamikacinMedicinebedaquilinePathologie maladies infectieusesintestine biopsyadultsteroidclinical trialGeneral MedicinerifabutinMicrobiologie et protistologie [entomologiephytoparasitolog.]priority journaldiabetes mellitushistopathologybiological productMicrobiology (medical)Microbiologie et protistologie [parasitologie hum. et anim.]medicine.medical_specialtyTuberculosis030106 microbiologymalignant neoplasmArticle03 medical and health scienceslaparotomyHuman immunodeficiency virus infectionmolecular diagnosisHumansTuberculosisGastro-intestinalhumanRetrospective Studiescolondisease predispositionmicrobiologyTuberculosis; Immune-suppression; Gastro-intestinal; Endoscopy;anusmedicine.diseasemajor clinical studymulticenter studyaminosalicylic acidcyclophosphamide0301 basic medicineBiopsyAntitubercular Agentsethambutolrifampicinterminal ileumcolonoscopyofloxacin030212 general & internal medicineLaparoscopyazathioprinemedicine.diagnostic_testIncidence (epidemiology)gastrointestinal tuberculosisDisease Managementchronic kidney failurecycloserineInfectious DiseasesfemaleTreatment OutcomeMolecular Diagnostic Techniquesdiagnostic testDisease Susceptibilitymedicine.symptommoxifloxacinSymptom AssessmentImmune-suppressionstomachisoniazidpyrazinamidestreptomycinliver cirrhosispatient referrallinezolidInternal medicineBiopsybusiness.industryEndoscopyMycobacterium tuberculosishuman tissueclinical featureTreatmentTuberculosis Gastrointestinaltuberculostatic agentbusinessMicrobiologie et protistologie [bacteriol.virolog.mycolog.]
researchProduct

The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir

2019

Chitosan is object of pharmaceutical research as a candidate permeability enhancer. However, chitosan was recently shown to reduce the oral bioavailability of acyclovir in humans. The effect of chitosan on two processes determining the oral bioavailability of acyclovir, bioaccessibility and intestinal absorption, was now investigated. Acyclovir's bioaccessibility was studied using the dynamic TNO gastro-Intestinal Model (TIM-1). Four epithelial models were used for permeability experiments: a Caco-2 cell model in absence and presence of mucus and both rat and porcine excised intestinal segments. Study concentrations of acyclovir (0.8 g/l) and chitosan (1.6 g/l and 4 g/l) were in line with t…

SwineAcyclovirPharmaceutical ScienceBiocompatible Materials02 engineering and technologyPharmacology030226 pharmacology & pharmacyIN-VITRO EVALUATIONIntestinal absorptionChitosanchemistry.chemical_compound0302 clinical medicineDrug InteractionsPharmacology & PharmacyGeneral MedicinePermeation021001 nanoscience & nanotechnologyMOLECULAR-WEIGHTJejunum0210 nano-technologyLife Sciences & BiomedicineBiotechnologyAbsorption (skin)Antiviral AgentsPermeability03 medical and health sciencesOrgan Culture TechniquesIn vivomedicineAnimalsHumansBiologyABSORPTION ENHANCERSChitosanScience & TechnologyIntestinal permeabilityCACO-2Caco-2medicine.diseaseTRANSPORTRatsBioavailabilityMODELIntestinal AbsorptionchemistryCOMMON EXCIPIENTSCaco-2Intestinal tissue segmentsCaco-2 CellsTNO gastro-Intestinal Model (TIM-1)SYSTEMPOORLY ABSORBABLE DRUGSTRACTEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Nouvelles stratégies de stabilisation des bactéries extrêmement sensibles à l’oxygène : cas du probiotique Faecalibacterium prausnitzii.

2016

Intestinal bacteria are of growing interest in the areas of health and wellness [1, 3]. The intestinal ecosystem is characterized by its complex composi-tion and its very low oxygen content. Therefore, nu-merous bacterial species isolated from this environ-ment are extremely sensitive to oxygen. This feature is responsible for the difficulty of implementation of these microorganisms for probiotic large-scale appli-cations, particularly during processing and storage. In this presentation, we present the main steps that have been overcome to conserve and design a stabilization strategy for the bacteria Faecalibacterium prausnitzii, recognized for their anti-inflammatory activities intestinal …

Tractus gastro-intestinal.[SDV.IDA]Life Sciences [q-bio]/Food engineering[ SDV.IDA ] Life Sciences [q-bio]/Food engineeringAnaérobieEncapsulationGastro-intestinal tract.[SDV.IDA] Life Sciences [q-bio]/Food engineeringProbioticProbiotiquesPreservationAnaerobe
researchProduct